Farther Finance Advisors’s Jade Biosciences JBIO Stock Holding History

Farther Finance Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$450	Sell	32 -34	-52%	-$682	﹤0.01%	5771
2026 Q2	$1.46K	Sell	66 -12	-15%	-$250	﹤0.01%	5269
2026 Q1	$1.25K	Buy	78 +1	+1%	+$14	﹤0.01%	5040
2025 Q4	$1.19K	Hold	77	–	–	﹤0.01%	4870
2025 Q3	$665	Buy	77 +61	+381%	+$498	﹤0.01%	4471
2025 Q2	$160	Buy	+16	New	+$545	﹤0.01%	4243

Other funds holding JBIO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's JBIO Position: Q3 2026 in Review

Farther Finance Advisors reduced its Jade Biosciences (JBIO) stake by 52% in Q3 2026, selling an estimated $682 and leaving 32 shares worth $450. The position accounts for ﹤0.01% of the portfolio, ranked #5771.

Farther Finance Advisors first reported a position in JBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.46K in Q2 2026. 5 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

Farther Finance Advisors held 32 shares of Jade Biosciences worth $450 as of Q3 2026.
Farther Finance Advisors sold 34 Jade Biosciences shares in Q3 2026, an estimated $682.
Jade Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5771 holding.
Farther Finance Advisors first reported a position in Jade Biosciences in Q2 2025 and has held it in 6 quarters since.
Farther Finance Advisors's Jade Biosciences position peaked at $1.46K in Q2 2026.
5 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.